Menu
Back to User profile » Dr Mahmoud H Teaima
Papers published by Dr Mahmoud H Teaima:
Screening of Adapalene Microsponges Fabrication Parameters with Insight on the In vitro Biological Effectiveness
Yehia RM, Attia DA, Elmazar MM, El-Nabarawi MA, Teaima MH
Drug Design, Development and Therapy 2022, 16:3847-3864
Published Date: 4 November 2022
Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats
Teaima M, Abdelmonem R, Adel YA, El-Nabarawi MA, El-Nawawy TM
Drug Design, Development and Therapy 2021, 15:4603-4614
Published Date: 10 November 2021
A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study
Teaima MH, Abdel-Haleem KM, Osama R, El-Nabarawi MA, Elnahas OS
Drug Design, Development and Therapy 2021, 15:4229-4242
Published Date: 7 October 2021
Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride
Naguib MJ, Elsayed I, Teaima MH
International Journal of Nanomedicine 2021, 16:2917-2931
Published Date: 21 April 2021
Promising Swellable Floating Bupropion Tablets: Formulation, in vitro/in vivo Evaluation and Comparative Pharmacokinetic Study in Human Volunteers
Teaima M, Abdel Hamid MM, Shoman NA, Jasti BR, El-Nabarawi MA
Drug Design, Development and Therapy 2020, 14:2741-2757
Published Date: 14 July 2020
Proniosomal Telmisartan Tablets: Formulation, in vitro Evaluation and in vivo Comparative Pharmacokinetic Study in Rabbits
Teaima MH, Yasser M, El-Nabarawi MA, Helal DA
Drug Design, Development and Therapy 2020, 14:1319-1331
Published Date: 31 March 2020
Assessment Of Spanlastic Vesicles Of Zolmitriptan For Treating Migraine In Rats
El-Nabarawy NA, Teaima MH, Helal DA
Drug Design, Development and Therapy 2019, 13:3929-3937
Published Date: 21 November 2019
Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl
El Nabarawi MA, Teaima MH, Abd El-Monem RA, El Nabarawy NA, Gaber DA
Drug Design, Development and Therapy 2017, 11:1081-1093
Published Date: 3 April 2017